TFRC and polycystic ovary syndrome: As we delved deeper into our perplexing results, we observed that the expression of TFRC and ACSL4 was significantly upregulated in the n-3 PUFA-treated group compared to the PCOS group, while the expression trends of SLC7A11, FTH, and FTL were flipped on their heads (Figure 4f).